|
US4816567A
(en)
|
1983-04-08 |
1989-03-28 |
Genentech, Inc. |
Recombinant immunoglobin preparations
|
|
DE3484377D1
(de)
|
1983-06-15 |
1991-05-08 |
Celltech Ltd |
Peptide, pharmazeutische zusammensetzungen, gene, vektoren, wirtorganismen, verfahren zu deren herstellung und diagnostische reagenzien.
|
|
DK27885A
(da)
|
1985-01-22 |
1986-07-23 |
Novo Industri As |
Fremstilling af peptider
|
|
EP0593065B1
(en)
|
1985-09-12 |
2002-08-21 |
Scios Inc. |
Recombinant fibroblast growth factors
|
|
US5118666A
(en)
|
1986-05-05 |
1992-06-02 |
The General Hospital Corporation |
Insulinotropic hormone
|
|
US6858409B1
(en)
|
1988-05-27 |
2005-02-22 |
Amgen Inc. |
Nucleic acids encoding interleukin-1 inhibitors and processes for preparing interleukin-1 inhibitors
|
|
US5075222A
(en)
|
1988-05-27 |
1991-12-24 |
Synergen, Inc. |
Interleukin-1 inhibitors
|
|
CA1339210C
(en)
|
1988-05-31 |
1997-08-05 |
John Lewicki |
Recombinant techniques for production of novel natriuretic and vasodilator peptides
|
|
US5114923A
(en)
|
1988-05-31 |
1992-05-19 |
California Biotechnology Inc. |
Recombinant techniques for production of novel natriuretic and vasodilator peptides
|
|
US5534617A
(en)
|
1988-10-28 |
1996-07-09 |
Genentech, Inc. |
Human growth hormone variants having greater affinity for human growth hormone receptor at site 1
|
|
US5631230A
(en)
|
1989-09-21 |
1997-05-20 |
Arizona Technology Development Corporation |
Receptor selective analogues of cholecystokinin-8
|
|
US5175146A
(en)
|
1989-12-05 |
1992-12-29 |
Vical, Inc. |
Synthetic calcitonin peptides
|
|
US5364840A
(en)
|
1989-12-05 |
1994-11-15 |
Vical, Inc. |
Synthetic calcitonin peptides
|
|
EP0548267A4
(en)
|
1990-09-04 |
1994-11-23 |
Salk Inst Biotech Ind |
Production of insulin-like growth factor-1 in methylotrophic yeast cells
|
|
US5234906A
(en)
|
1991-01-10 |
1993-08-10 |
Amylin Pharmaceuticals, Inc. |
Hyperglycemic compositions
|
|
US5206161A
(en)
|
1991-02-01 |
1993-04-27 |
Genentech, Inc. |
Human plasma carboxypeptidase B
|
|
HU222249B1
(hu)
|
1991-03-08 |
2003-05-28 |
Amylin Pharmaceuticals Inc. |
Eljárás amilin agonista peptidszármazékok és ezeket tartalmazó gyógyszerkészítmények előállítására
|
|
EP1400536A1
(en)
|
1991-06-14 |
2004-03-24 |
Genentech Inc. |
Method for making humanized antibodies
|
|
KR960701653A
(ko)
|
1993-03-29 |
1996-03-28 |
발라수브라마니암 엠비카이파칸 |
펩타이드 yy의 유사체 및 그의 용도
|
|
US5759551A
(en)
|
1993-04-27 |
1998-06-02 |
United Biomedical, Inc. |
Immunogenic LHRH peptide constructs and synthetic universal immune stimulators for vaccines
|
|
US5424286A
(en)
|
1993-05-24 |
1995-06-13 |
Eng; John |
Exendin-3 and exendin-4 polypeptides, and pharmaceutical compositions comprising same
|
|
US6491916B1
(en)
|
1994-06-01 |
2002-12-10 |
Tolerance Therapeutics, Inc. |
Methods and materials for modulation of the immunosuppresive activity and toxicity of monoclonal antibodies
|
|
US5885573A
(en)
|
1993-06-01 |
1999-03-23 |
Arch Development Corporation |
Methods and materials for modulation of the immunosuppressive activity and toxicity of monoclonal antibodies
|
|
US5574010A
(en)
|
1994-11-14 |
1996-11-12 |
The Regents Of The University Of California |
Treatment of pancreatic tumors with peptide YY and analogs thereof
|
|
US5532336A
(en)
|
1995-01-31 |
1996-07-02 |
Eli Lilly And Company |
Anti-obesity proteins
|
|
US5521283A
(en)
|
1995-01-31 |
1996-05-28 |
Eli Lilly And Company |
Anti-obesity proteins
|
|
US6214797B1
(en)
|
1995-06-13 |
2001-04-10 |
The Salk Institute For Biological Studies |
Urocortin peptides, nucleic acid encoding same methods for using same
|
|
DE69602756T2
(de)
|
1995-08-18 |
2000-02-10 |
The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services, Rockville |
Funktionelle rolle von adrenomedullin(am) und dem gen-verwandten produkt(pamp) in der menschlichen pathologie und physiologie
|
|
US6936439B2
(en)
|
1995-11-22 |
2005-08-30 |
Amgen Inc. |
OB fusion protein compositions and methods
|
|
EP0983303B1
(en)
|
1997-05-21 |
2006-03-08 |
Biovation Limited |
Method for the production of non-immunogenic proteins
|
|
US20020042367A1
(en)
|
1997-11-25 |
2002-04-11 |
Genentech, Inc. |
Fibroblast growth factor-19 (FGF-19) nucleic acids and polypeptides and methods of use for the treatment of obesity and related disorders
|
|
US6406632B1
(en)
|
1998-04-03 |
2002-06-18 |
Symyx Technologies, Inc. |
Rapid characterization of polymers
|
|
GB9815157D0
(en)
|
1998-07-13 |
1998-09-09 |
Metron Designs Ltd |
High resolution pulse width setting from relatively low frequency clocks
|
|
WO2000057183A1
(en)
*
|
1999-03-23 |
2000-09-28 |
Biovation Limited |
Protein isolation and analysis
|
|
ES2401939T3
(es)
|
1999-07-23 |
2013-04-25 |
Kenji Kangawa |
Nuevos péptidos
|
|
US6716626B1
(en)
|
1999-11-18 |
2004-04-06 |
Chiron Corporation |
Human FGF-21 nucleic acids
|
|
CA2739933A1
(en)
|
2000-02-11 |
2001-08-16 |
Bayer Healthcare Llc |
Factor vii or viia-like molecules
|
|
JP4237375B2
(ja)
|
2000-03-31 |
2009-03-11 |
アスビオファーマ株式会社 |
虚血性疾患の処置又は予防に用いる医薬組成物
|
|
US6967237B2
(en)
|
2000-05-30 |
2005-11-22 |
Merck & Co., Inc. |
Ghrelin analogs
|
|
US20030228309A1
(en)
|
2000-11-08 |
2003-12-11 |
Theodora Salcedo |
Antibodies that immunospecifically bind to TRAIL receptors
|
|
US20020119490A1
(en)
*
|
2000-12-26 |
2002-08-29 |
Aebersold Ruedi H. |
Methods for rapid and quantitative proteome analysis
|
|
WO2002079415A2
(en)
|
2001-03-30 |
2002-10-10 |
Lexigen Pharmaceuticals Corp. |
Reducing the immunogenicity of fusion proteins
|
|
US7419949B2
(en)
|
2001-07-16 |
2008-09-02 |
Novo Noridsk Healthcare A/G |
Single-dose administration of factor VIIa
|
|
US7294513B2
(en)
|
2002-07-24 |
2007-11-13 |
Wyatt Technology Corporation |
Method and apparatus for characterizing solutions of small particles
|
|
US6965013B2
(en)
|
2002-11-26 |
2005-11-15 |
The Board Of Trustees Of The Leland Stanford Junior University |
Intermedin and its uses
|
|
US7166575B2
(en)
|
2002-12-17 |
2007-01-23 |
Nastech Pharmaceutical Company Inc. |
Compositions and methods for enhanced mucosal delivery of peptide YY and methods for treating and preventing obesity
|
|
ES2396368T3
(es)
|
2003-03-03 |
2013-02-21 |
Dyax Corporation |
Péptidos que se unen específicamente al receptor del HGF (CMET) y usos de los mismos
|
|
CA2569509C
(en)
|
2004-06-03 |
2014-08-12 |
Novimmune S.A. |
Anti-cd3 antibodies and methods of use thereof
|
|
CN101309703A
(zh)
|
2005-09-12 |
2008-11-19 |
诺维莫尼公司 |
抗cd3抗体组合物
|
|
CA2989778C
(en)
|
2007-01-19 |
2020-06-30 |
Kai Pharmaceuticals, Inc. |
Method of modifying peptide compositions
|
|
EP2370467B1
(en)
|
2008-10-01 |
2016-09-07 |
Amgen Research (Munich) GmbH |
Cross-species-specific pscaxcd3, cd19xcd3, c-metxcd3, endosialinxcd3, epcamxc d3, igf-1rxcd3 or fapalpha xcd3 bispecific single chain antibody
|
|
US8703717B2
(en)
|
2009-02-03 |
2014-04-22 |
Amunix Operating Inc. |
Growth hormone polypeptides and methods of making and using same
|
|
ES2610356T3
(es)
|
2009-02-03 |
2017-04-27 |
Amunix Operating Inc. |
Polipéptidos recombinantes extendidos y composiciones que comprenden los mismos
|
|
US8680050B2
(en)
|
2009-02-03 |
2014-03-25 |
Amunix Operating Inc. |
Growth hormone polypeptides fused to extended recombinant polypeptides and methods of making and using same
|
|
WO2010144508A1
(en)
|
2009-06-08 |
2010-12-16 |
Amunix Operating Inc. |
Glucose-regulating polypeptides and methods of making and using same
|
|
AU2015200260A1
(en)
*
|
2009-06-08 |
2015-02-12 |
Amunix Operating Inc. |
Glucose-regulating polypeptides and methods of making and using same
|
|
KR101813727B1
(ko)
|
2009-06-08 |
2018-01-02 |
아뮤닉스 오퍼레이팅 인코포레이티드 |
성장 호르몬 폴리펩타이드 및 이를 제조하고 사용하는 방법
|
|
CA2771999A1
(en)
|
2009-08-24 |
2011-03-10 |
Amunix Operating Inc. |
Coagulation factor vii compositions and methods of making and using same
|
|
WO2011028344A2
(en)
|
2009-08-25 |
2011-03-10 |
Amunix Operating Inc. |
Interleukin-1 receptor antagonist compositions and methods of making and using same
|
|
CN104661674A
(zh)
|
2012-07-11 |
2015-05-27 |
阿穆尼克斯运营公司 |
具有xten和血管性血友病因子蛋白的因子viii复合物、及其用途
|
|
TW202003554A
(zh)
|
2013-08-14 |
2020-01-16 |
美商百歐維拉提夫治療公司 |
因子ｖｉｉｉ－ｘｔｅｎ融合物及其用途
|
|
MX2017006016A
(es)
*
|
2014-11-11 |
2017-06-19 |
Amunix Operating Inc |
Composiciones conjugadas de xten direccionadas y metodos para producir las mismas.
|
|
WO2016145416A2
(en)
*
|
2015-03-11 |
2016-09-15 |
The Broad Institute, Inc. |
Proteomic analysis with nucleic acid identifiers
|
|
US9601471B2
(en)
|
2015-04-23 |
2017-03-21 |
Apple Inc. |
Three layer stack structure
|
|
JP6558679B2
(ja)
|
2015-04-24 |
2019-08-14 |
パナソニックＩｐマネジメント株式会社 |
点灯装置、照明装置及び照明器具
|
|
AU2016253964B2
(en)
*
|
2015-04-27 |
2022-07-07 |
Abvitro Llc |
Methods of sequencing, determining, pairing, and validating therapeutic agents and disease specific antigens
|
|
US11339434B2
(en)
*
|
2016-07-29 |
2022-05-24 |
The Regents Of The University Of California |
Methods for determining gene functions
|
|
WO2019074841A1
(en)
*
|
2017-10-09 |
2019-04-18 |
Pioneer Hi-Bred International, Inc. |
TYPE I-E CRISPR-CAS SYSTEMS FOR EUCARYOTE GENOME EDITION
|
|
AU2018393111B2
(en)
*
|
2017-12-21 |
2025-07-10 |
Amunix Pharmaceuticals, Inc. |
Release segments and binding compositions comprising same
|